Animals And Research

I am writing to comment on the letter from Donald J. Barnes, director of the National Antivivisection Society [The Scientist, Jan. 7, 1991, page 16]. In response to Albert Kligman's challenge to antivivisectionists to openly debate their positions with members of the scientific establishment [The Scientist, Oct. 29, 1990, page 16], Barnes complains that "it is increasingly difficult to find members of the active biomedical research community who will agree to such debates within our public inst

Written byCharles Nicoll
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I am writing to comment on the letter from Donald J. Barnes, director of the National Antivivisection Society [The Scientist, Jan. 7, 1991, page 16]. In response to Albert Kligman's challenge to antivivisectionists to openly debate their positions with members of the scientific establishment [The Scientist, Oct. 29, 1990, page 16], Barnes complains that "it is increasingly difficult to find members of the active biomedical research community who will agree to such debates within our public institutions." He also states that he would be delighted to debate the issue of animal use in research and testing.

If Barnes is having trouble finding opponents in his neighborhood to debate him on this controversy, I would suggest that he go west. I have debated with antivivisectionists and animal rightists on numerous occasions in recent years, and I would be pleased to have Barnes as an opponent. A format that might appeal to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies